These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 1423314

  • 21. Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells.
    Guo XJ, Chambers AF, Parfett CL, Waterhouse P, Murphy LC, Reid RE, Craig AM, Edwards DR, Denhardt DT.
    Cell Growth Differ; 1990 Jul; 1(7):333-8. PubMed ID: 2177633
    [Abstract] [Full Text] [Related]

  • 22. [The relationship between metastatic phenotype and steady expression of BGC-Ha-ras oncogene from metastasis cell lines in nude mice (abstract)].
    Li YJ.
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):402-5. PubMed ID: 1349521
    [Abstract] [Full Text] [Related]

  • 23. Differential growth factor expression in transformed mouse NIH-3T3 cells.
    Ciardiello F, Valverius EM, Colucci-D'Amato GL, Kim N, Bassin RH, Salomon DS.
    J Cell Biochem; 1990 Jan; 42(1):45-57. PubMed ID: 1967612
    [Abstract] [Full Text] [Related]

  • 24. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ, Sitrin RG.
    J Immunol; 1990 Mar 01; 144(5):1873-9. PubMed ID: 2307845
    [Abstract] [Full Text] [Related]

  • 25. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
    Lebeau J, Le Chalony C, Prosperi MT, Goubin G.
    Oncogene; 1991 Jul 01; 6(7):1125-32. PubMed ID: 1861862
    [Abstract] [Full Text] [Related]

  • 26. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gänsbacher B, Schmitt M.
    Cancer Gene Ther; 2000 Feb 01; 7(2):292-9. PubMed ID: 10770639
    [Abstract] [Full Text] [Related]

  • 27. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD, Hernandez OM, Hebel D, Root M, Pow-Sang JM, Wickstrom E.
    Cancer Res; 1993 Feb 01; 53(3):577-80. PubMed ID: 8425190
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Downstream sequences mediate induction of the mouse cathepsin L promoter by phorbol esters.
    Troen BR, Chauhan SS, Ray D, Gottesman MM.
    Cell Growth Differ; 1991 Jan 01; 2(1):23-31. PubMed ID: 1848774
    [Abstract] [Full Text] [Related]

  • 30. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.
    Chambers AF, Behrend EI, Wilson SM, Denhardt DT.
    Anticancer Res; 1992 Jan 01; 12(1):43-7. PubMed ID: 1567180
    [Abstract] [Full Text] [Related]

  • 31. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
    Mohanam S, Jasti SL, Kondraganti SR, Chandrasekar N, Kin Y, Fuller GN, Lakka SS, Kyritsis AP, Dinh DH, Olivero WC, Gujrati M, Yung WK, Rao JS.
    Clin Cancer Res; 2001 Aug 01; 7(8):2519-26. PubMed ID: 11489835
    [Abstract] [Full Text] [Related]

  • 32. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.
    Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF.
    Cancer Res; 1994 Feb 01; 54(3):832-7. PubMed ID: 8306346
    [Abstract] [Full Text] [Related]

  • 33. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
    Pustilnik TB, Estrella V, Wiener JR, Mao M, Eder A, Watt MA, Bast RC, Mills GB.
    Clin Cancer Res; 1999 Nov 01; 5(11):3704-10. PubMed ID: 10589790
    [Abstract] [Full Text] [Related]

  • 34. Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor.
    Stacey KJ, Fowles LF, Colman MS, Ostrowski MC, Hume DA.
    Mol Cell Biol; 1995 Jun 01; 15(6):3430-41. PubMed ID: 7760840
    [Abstract] [Full Text] [Related]

  • 35. Conditioned medium from ras oncogene-transformed NIH 3T3 cells induces bone resorption in vitro.
    Krieger NS, Sukhatme VP, Bushinsky DA.
    J Bone Miner Res; 1990 Feb 01; 5(2):159-64. PubMed ID: 2180257
    [Abstract] [Full Text] [Related]

  • 36. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
    Chambers AF, Colella R, Denhardt DT, Wilson SM.
    Mol Carcinog; 1992 Feb 01; 5(3):238-45. PubMed ID: 1586450
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antisense GLUT1 RNA suppresses the transforming phenotypes of NIH 3T3 cells transformed by N-Ras.
    Choi JW, Yoon DJ, Lee HW, Han DP, Ahn YH.
    Yonsei Med J; 1995 Dec 01; 36(6):480-6. PubMed ID: 8599249
    [Abstract] [Full Text] [Related]

  • 40. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression.
    Botteri FM, Ballmer-Hofer K, Rajput B, Nagamine Y.
    J Biol Chem; 1990 Aug 05; 265(22):13327-34. PubMed ID: 1695907
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.